NCT01605318 2024-01-24Study of Labetuzumab Govitecan in Participants With Metastatic Colorectal CancerGilead SciencesPhase 1/2 Terminated92 enrolled
NCT01841021 2017-01-19Pilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30H. Lee Moffitt Cancer Center and Research InstitutePhase NA Terminated1 enrolled 5 charts